Robert E. Gagnon - 08 Jan 2024 Form 4 Insider Report for Bone Biologics Corp (BBLG)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BBLG	Non-Employee Stock Option	Award	$0	+9		$0.00	9	08 Jan 2024	Common Stock	9	$4.68	Direct	F1
transaction	BBLG	Non-Employee Stock Option	Award	$0	+8.01	+0.1%	$0.00	8.02K	08 Jan 2024	Common Stock	8.01K	$4.68	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable on the date of the next annual meeting of the stockholders of the Company following the grant date.
F2	This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, 2,003 options are immediately exercisable with the remaining 6,003 options vesting and becoming exercisable in three equal installments on 3/12/2024, 6/12/2024, and 9/12/2024.